chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Muscular pain (severe at times) in the upper (deltoid) areas of both arms, leading up into the shoulders and neck on both sides.  Also, pain in backs of thighs, extending from top of thighs to backs of knees.  Very painful to sit for any length of time.  Limited motion in arms, as well as inability to bend over without experiencing pain.
Covid-19 Janssen vaccination administered on 5/24/2021 at approximately 1230. At approximately 1247 patient noted to have flat red rash to left side of neck moving towards chest and same rash on left antecubital space. Patient reported feeling hot. Diphenhydramine 50mg IM administered. Patient reported feeling short of breath, epi-pen 0.3mg IM administered. Respirations at 16 per minute,  lungs clear to auscultation. Noted bilateral flat rash to underarms, improved with removing clothing from area. Patient symptoms improved. At approximately 1330 patient reported starting to feel short of breath. Patient self administered albuterol inhaler, two puffs.  Lung sounds per auscultated expiratory wheezing bilateral upper posterior lobes and right middle lobe, no stridor.  Post inhaler lung sounds very faint expiratory wheezing upper posterior lobe, right middle lobe cleared.  At approximately 1400 noted rash to bilateral underarms started to return, rash to left side of neck started to raise, noted dermatography to bilateral sides. EMS activated. Perioral edema noted, patient reported starting to feel short of breath, epi-pen 0.3mg IM administered, oxygen at 2L per NC applied. Ambulance on prison grounds at approximately 1412, left grounds at approximately 1429 to Emergency Room for a higher level of care.  Treatment at  ER not available. Discharged from  ER on same date at 2246.  On 5/25/2021 at approximately 0215 patient reported pain in jaw, neck and chest. EKG obtained,  normal EKG. Follow up scheduled with medical provider.
Information has been received from a registered nurse concerning an outbreak of chickenpox in a child, between the ages of kindergarten to 4th grade, who had been vaccinated subcutaneously with a first dose of 0.5 mL of varicella virus vaccine live (Oka/Merck). Subsequently, the child developed chickenpox. The child may have 50 lesions or more. Additional information is not expected. This is one of several reports received from the same source.
When I received my first two covid shots in 2021, my testosterone levels dropped. After my testosterone dropped, I had to visit a urologist to receive medication to increase my natural levels of testosterone back to normal. The decreased levels of testosterone lasted me for around six months. I later developed a musculoskeletal soreness within my pictorial muscles. This pictorial injury has lasted me almost a year and I have gone to a general practitioner to receive anti-inflammatory medicine and muscle relaxers to heal my chest. But my chest pain still lingers almost a year later. This chest pain has been Amplified after I received my booster shot, which was the third covid shot in 2022.
Influenza vaccine administered at 7:30 am. By 10:00 am developed sore throoat, cough, progressed to chest tightness difficulty swallowing by 11:30 am. Directed employee to the ER for treatment
ulcerative colitis; This is a spontaneous report. A contactable consumer (patient) reported that a patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported.  The patient had ulcerative colitis and currently received infusions of Remicade. The patient just got a booster vaccine and wanted to know if there would be a test for antibodies before infusion on 06Sep2021 and after to see how Remicade affected the antibodies. The outcome of the event was unknown.  Information on the Lot/batch number has been requested.
Member received his COVID vaccine on 10/11/23 and on 10/12/23 was noted laying on the floor unresponsive, blood coming from his mouth with seizure like activity.
severe, prolonged crying began 2 1/2 hrs inject given persisted 3 1/2 hrs; they took pt to ER to be checked; no rx, only recommended APAP q 4 hrs;
pt states reaction site swollen, red.  Redness and irritation seem to be traveling from arm to back of neck.  Recommended pt apply ice, use tylenol or ibuprofen, contact dr if symptoms worsen or do not improve.
Allergy attacks, tiredness, severe head and neck pains, unable to lift arms because shoulders were extremely sore, hip and back pains, inflammation throughout the body.
HEART RACING/HEART RATE HIGH; BAD HEADACHE; MILD FEVER; BODY ACHE; CHILLS; MALAISE; This spontaneous report received from a patient concerned a 62 year old female. The patient's height, and weight were not reported. The patient's past medical history included patient takes no medications and has no medical conditions.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 042A21A, expiry: UNKNOWN) dose was not reported, administered on 03-APR-2021 17:00 for prophylactic vaccination. No concomitant medications were reported. On 04-APR-2021, the subject experienced body ache. On 04-APR-2021, the subject experienced chills. On 04-APR-2021, the subject experienced malaise. On 04-APR-2021, the subject experienced mild fever. On 04-APR-2021 03:00, the subject experienced heart racing/heart rate high. On 04-APR-2021 03:00, the subject experienced bad headache. Laboratory data (dates unspecified) included: Heart rate increased (NR: not provided) >90 /min. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body ache, chills, bad headache, and mild fever on 04-APR-2021, was recovering from malaise, and had not recovered from heart racing/heart rate high. This report was non-serious.
Information has been received from a male patient concerning himself who on approximately 17-JAN-2010 ("last week") was vaccinated with the first 0.5ml dose of GARDASIL (lot# not reported). He reported that he was experiencing pain and swelling the backside of neck and underneath the jaw. At the time of this report, the patient had not recovered. No further information is available.
Patient experience syncopy right after the flu vaccine was administered.  Patient reported not feeling well when the bandage was being put on the injection site and became limp on the chair she was sitting.  She seemed to have lost consciousness for less than a minute and woke up and vomited a little bit of fluid due to nausea.  She rested for about 30 minutes in the sitting position with head down on the table and was able to walk out of the pharmacy to go home with her mom.
redness, swelling at the site. Fever of 103.7 developed  3 days after vaccines were administered.
MMR, Varicella and Comvax given 9/12/03. C/o itchy rash on 9/14/03. Came as walk in to clinic on 9/16/04 and seen. Dx with allergic rash. No respiratory problem noted. Had appt to RTC on 9/17/03, did not return.
ED Discharged  4/21/2021 (5 hours)  Treatment team COVID-19 Clinical impression Covid+ Chief complaint ED Provider Notes PA (Physician Assistant) ? ? Emergency Medicine Cosigned by: DO at 4/21/2021 10:52 PM Expand AllCollapse All    ED PROVIDER NOTE     History provided by: Patient Language interpreter used:   No   CHIEF COMPLAINT:   Chief Complaint Patient presents with ? Covid+   Encounter Details  Date Type Department Care Team Description 04/23/2021 Office Visit  Covid - 19 Testing Site   Contact w and exposure to oth viral communicable diseases (Primary Dx);  2019 novel coronavirus detected  ED Discharged  4/28/2021 (3 hours) Treatment team COVID-19 Clinical impression Medication Infusion Chief complaint ED Provider Notes Emergency Medicine Expand AllCollapse All    Chief Complaint Patient presents with ? Medication Infusion     HPI Patient presents here for monoclonal antibody infusion for Covid.  He was diagnosed with Covid 1 week ago.  He has having cough, congestion, myalgias, nausea and abdominal pain.  Minimal shortness of breath.  Severity of symptoms right now is mild to moderate.  He has a history of coronary artery disease, diabetes and hypertension.     Orders Only Open  5/5/2021 Diarrhea due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection Dx Orders Placed   COVID-19 PCR Medication Changes   None   Medication List  Visit Diagnoses   Diarrhea due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
Approx 10 days after the vaccination, a large rash appeared on arm at vaccine site, it's warm to the touch, and was extremely itchy for a few days. There is a brighter red ring around the perimeter of the rash. Itchiness subsided after a few days, but the rash continued to spread. It is slightly painful/sore to the touch.
Left jaw pain slightly radiating into ear. Pain level 4/10; Left jaw pain slightly radiating into ear. Pain level 4/10; This is a spontaneous report from a contactable consumer. A 57-year-old female patient received the first dose of bnt162b2 (BNT162B2, lot number: EK5730, expiration date was not reported), via an unspecified route of administration on the left arm on 18Dec2020 09:30 at single dose for immunisation. Medical history included controlled hypertension (HTN) and allergies to milk products. Concomitant medication included meloxicam (MOBIC), escitalopram oxalate (LEXAPRO) and irbesartan. The patient was not diagnosed with COVID-19 prior to vaccination. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. On 19Dec2020 at 07:00, the patient experienced left jaw pain slightly radiating into ear. Pain level 4/10. No treatment was given for the events. The patient has not been tested for COVID-19 since the vaccination. The patient has not recovered from the events.
4 varicella like rash on injection site (R) anterior thigh - treated with mupirocin ointment. Papular-vesicular rash notes 2/24/19, 18 days days after above vaccines were given, as per mom rashes hurt.
In menopause for over two years and I started spotting June 3rd and have been spotting ever since.
Quarter size bruise around injection site and a secondary bruise about an inch beneath first bruise. Second bruise is twice the size and has  a more diffuse border than the first. Some arm warmth and swelling as well.
This spontaneous report as received from a certified medical assistant refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 25-AUG-2015, the patient was vaccinated with an expired dose of PNEUMOVAX 23 (0.5 ml, intramuscularly, in the right arm, lot # K004542, expiration date 19-AUG-2015). No adverse effects were reported. Additional information is not expected as the reporter did not wish to be contacted.
Serious case of hives that continued for a week. They were itchy and painful. I was put on Prednisone, Claritin,   & Benadryl. The hives continued & I went to the local ER and was placed on an additional medicine, Pepcid.  They finally eased off.
Systemic: Generalized Body Aches -Medium, Systemic: Nausea-Medium, Systemic: Light-headedness and difficulty breathing-Medium
Patient received first dose of Moderna COVID-19 vaccine on 12/31/20. She took Zyrtec and tylenol 30 minutes before the injection as premedication.  She was observed after the injection, felt skin itching after 11 minutes. Nurse checked her BP was 137/67 and temperature was 97F. After 10 minutes BP was 114/60 and temperature was 99.1F. Skin pruritus felt worse. Patient stayed an hour under observation and was sent home.   At home that day felt throbbing headache and sore throat.  Had fever of 101 and emesis 6 times. She took Zofran and 4 more doses of Zyrtec that day. Next day pruritus resolved. Still had headache and temperature 100.2. Took tylenol every 4-6 hours. The symptoms all resolved after 2 days. No cough or shortness of breath.
Alert received in system on 1/15/21 at 1920 showing treated VT event.  Patient had what appears to be slow VT 136bpm for total duration of 1 min 25 sec.  Device attempted ATP 7 times unsuccessfully which then resulted in 1 shock at 22J which was successful.  Called and spoke with patient who says that he has received the COVID vaccine that morning.  He began to feel a bit run down in the afternoon and was aware that he received a shock.
Extreme swelling, redness, itching, burning, pain at injection site=five days. Extreme diarrhea, vomiting and weakness or sick feeling for 5-6 days.
p/vax pt exp severe inj site rxn w/erythema, warmth, pain & swelling;pt recovered 3-4 days p/onset of sx;
Later in the day (4/22) my eyes started watering.  The next morning  my left eye was red. After going to Eye Institute they examined me and said I have a busted blood vessel in my eye and small inflammation in the right eye
1/11/03 Took Anthrax vaccine and influenza vaccine. 1/12/03 Nausea, upset stomach, cold chills. 1/13/03 Weak, back and muscle aches, tired, cold chills. 1/14/03 Dizziness, cold chills, aches. Seen doctor on 1/14/03 and gave me nausea medicine.
This case was reported by a pharmacist via call center representative and described the occurrence of injection site pain in a 59-year-old female patient who received SHINGRIX (batch number 32GR4, expiry date 4th July 2020) for prophylaxis. On 22nd June 2018 12:00, the patient received SHINGRIX (intramuscular) .5 ml. In June 2018, less than a week after receiving SHINGRIX, the patient experienced injection site pain, injection site swelling, rash and injection site warmth. On an unknown date, the outcome of the injection site pain, injection site swelling, rash and injection site warmth were unknown. The reporter considered the injection site pain, injection site swelling and injection site warmth to be related to SHINGRIX. The reporter considered the rash to be unlikely related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX in the left deltoid. The patient developed pain, warmth at the injection site. The patient's injection site was raised. Sometime later, the patient developed an elongated rash on the front of her left arm.
I am continuing to have rashes develop all over my skin. Wherever I run or scratch my skin, it quickly turns red and becomes raised. Then it slowly goes away within 20-30 minutes. But the condition remains comtant. The rashes are  slightly irritating, not  very painful or itchy. However, I am certain this is a result of the vaccine.  I?ve never had anything remotely like this before. It?s continuing now for three months after the second shot.
Nausea and Diarrhea,  Colitis.  Received 1000cc normal saline, CT Scan of abd
Sore throat  fever cough   treated with Prednisone 10 Mg for 7 days andPromethazine 5 Ml  as needed
Varicella was ordered. Zostavax was given by mistake. No reaction by patient.
high heart rate after shot 140 BPM as shown on watch, 1 hour later extreme fatigue, pain at injection sight,  fever 101.6, headache, chills, sweating I woke up in a pool of sweat. Saturday all day dizziness, headache, chills. Sunday pain in all my joints and back and headache. Monday fatigue. Early period by 1 week.
See below Patient is a 23 yof with history of vasovagal syncope  c/o syncope secondary to pfizer vaccine dose 1. Witness states she was pacing back and forth in the hallway when she fell from standing position to the ground hitting her head. She was maintained in the supine position and recovered spontaneously shortly after. Appearance was pale and diaphoretic. V/S were assessed. She was provided gatorade and seated in the green chair. She reported a pressure headache in the occipital region. She denies changes in vision, numbness and tingling in hands and feet, pain in her neck or spine, and history of blood thinners. Boyfriend states she was extremely nervous prior to getting the vaccine. Patient reported
Inadvertently gave Pfizer COVID-19 mRNA vaccine when Moderna COVID-19 vaccine should have been given for the booster dose.
1 minute after vaccine received, patient reports feeling mild tongue numbness. Patient denies respiratory distress. Patient given Certirizine 10 mg 1 tab oral. Pt able to hydrate with water. Patient advised to follow up with primary care provider and to call 911 if symptoms persist or experience respiratory distress. Patient instructed to take Acetaminophen/Ibuprofen, to have food/fluid, and to rest. Patient ambulatory and reports symptoms resolved after 30 minutes. Patient reports able to return to work. Patient declined transportation to hospital for further evaluation. BP128/82, HR 84.
This case was reported by a nurse via sales rep and described the occurrence of itchy rash in a 75-year-old male patient who received Shingrix for prophylaxis. On 30th July 2018, the patient received the 1st dose of Shingrix. On 31st July 2018, 1 days after receiving Shingrix, the patient experienced itchy rash. The patient was treated with nystatin and Clobetaso). On an unknown date, the outcome of the itchy rash was not recovered/not resolved. The reporter considered the itchy rash to be related to Shingrix. Additional details were provided as follows: The patient received Shingrix at a local pharmacy and on the next day the patient developed a rash around neck, forehead and both hands. As per reporter no other vaccine was administered on the same day. The reporter said the patient still has the rash and it has been three weeks since the vaccine was administered. The patient and reporter believed the adverse reaction was related to the vaccine. The patient visited his doctor's office and concerned about this reaction. On 16th August 2018, the nurse spoke to reporter and she provided some additional details regarding this adverse event report. The patient was seen in the physician's office on 13th August 2018 when he reported that 3 weeks earlier he received Shingrix at a local pharmacy. The day after receiving Shingrix, the patient experienced a rash that was itchy but with no drainage. The patient had been applying Nystatin cream to the rash, but this did not help. The doctor prescribed Clobetasol when he was seen on 13th August 2018. However, patient has not returned to the office for follow up. The reporter agreed again that she would be open to follow up from safety.
fatigue, metallic taste in my mouth, fever of up to 104.7 every 2 weeks, loss of appetite; fatigue, metallic taste in my mouth, fever of up to 104.7 every 2 weeks, loss of appetite; fatigue, metallic taste in my mouth, fever of up to 104.7 every 2 weeks, loss of appetite; fatigue, metallic taste in my mouth, fever of up to 104.7 every 2 weeks, loss of appetite; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 61 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 25Mar2021 14:30 (Lot number: ER8732) at the age of 61 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: LEVOXYL; BYSTOLIC; DYAZIDE. Past drug history included: Penicillin, reaction(s): "Allergy"; Avalide, reaction(s): "Allergy". The following information was reported: FATIGUE (non-serious), DYSGEUSIA (non-serious), PYREXIA (non-serious), DECREASED APPETITE (non-serious) all with onset 18Jun2021, outcome "not recovered" and all described as "fatigue, metallic taste in my mouth, fever of up to 104.7 every 2 weeks, loss of appetite". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of fatigue, dysgeusia, pyrexia, decreased appetite.  Additional Information: Patient had not taken other vaccines in four weeks. Patient did not had Covid prior vaccination. Patient tasted Covid post vaccination. patient had allergy to shrimp.  No follow-up attempts are possible. No further information is expected.
COVID-19 virus test positive; COVID-19 virus test positive; This is a spontaneous report from a contactable consumer reporting for himself. A male patient of an unspecified age received the 1st dose of bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech), via an unspecified route of administration, on 05Jan2021, at single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced COVID-19 virus test positive (medically significant) on 07Jan2021 with outcome of unknown. The patient underwent lab tests and procedures which included COVID-19 virus test: positive on 07Jan2021.  The information on the lot/batch number has been requested.
This spontaneous report was received from a licensed practical nurse (L.P.N) via a telephone call, concerning a 2 year old female patient. No concurrent conditions or medical history were reported. On 26-MAR-2015, the patient was vaccinated with an improperly stored dose of (Oka-Merck) PROQUAD (Lot # K018142 Expiration date: 10-APR-2016) (dose, frequency and anatomical location of administration were not reported). No concomitant therapies or adverse experiences were reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same source. Additional information has been requested.
Patient began to cough after exiting immunization room. Mother obtained staffs attention and Pharmacist approached patient to realize patient could not speak. She nodded yes when asked if she felt as though her throat was closing. Patient gave thumbs up when asked if pharmacist could administer an Epipen. Pharmacist asked pharmacy staff to call 911. Epipen 0.3mg administered at 1:07pm. Patient could speak shorly after administration of Epipen.  EMS arrived and transported stable patient to hospital ER. Patient was sent home from hospital with Epipen.
Patient called today (9/28/15) to report severe arm pain and limited range of motion at injection site. Said that it had started approximately the day of administration but he waited to report thinking it would go away. Advising patient to ice and NSAIDS to see if he can get symptomatic relief.
Local redness-lt deltoid (no hive) w/in 15-30min p/immun;
Pt recvd vax 9JAN92 pt became ill 10JAN92 w/nausea, vomiting, diarrhea, & low grade fever; Taken to ER 12JAN92; was given rx for diarrhea, vomiting & sent home;
This spontaneous report was received from a physician via company representative, referring to a male patient of an unknown age. The patient's current conditions, drug reactions or allergies were not reported. On an unknown date, the patient was vaccinated with the first dose of GARDASIL (strength, route of administration, lot # and expiry date were not provided). Concomitant medications were not reported. After vaccination, the patient fainted. There was no product quality complaint involved. At the time of reporting, the outcome of syncope was unknown. The relatedness between syncope and vaccination with GARDASIL was not provided by the reporter. Additional information is not expected as it is not possible to contact the physician.
Moderna COVID-19 Vaccine EUA. Injection site pain lasted for 3 days. No symptoms for the next 3 days. On the 6th day after the shot, swollen armpit/armpit pain started. Not severe enough to justify seeking medical help. Lapse in arm pain to armpit pain was surprising.